| Formulary Chapter 11: Eye - Full Chapter
|
| 11.01 |
Administration of drugs to the eye |
|
|
| 11.02 |
Control of microbial contamination |
|
|
| 11.03 |
Anti-infective eye preparations |
|
|
| 11.03.01 |
Antibacterials |
|
|
Chloramphenicol
|
Formulary
|
Eye drops 0.5%
Eye ointment 1%
|
|
|
Chloramphenicol single use (Minims ® Chloramphenicol )
|
Formulary
|
Eye drops 0.5%
|
|
|
Ciprofloxacin (Ciloxan®)
|
Formulary
|
Eye drops 0.3% (contains preservative) 5ml
(Eye ointment discontinued April 2017)
|
|
|
Fusidic Acid (Fucithalmic®)
|
Formulary
|
Eye drops 1% M/R
|
|
|
Gentamicin
|
Formulary
|
Eye drops 0.3% (10ml)
|
|
|
Levofloxacin eye drops 5mg/ml
|
 Restricted
|
Available for:
- Secondary care – Perioperative Antimicrobial prophylaxis in ophthalmic surgery – formulary status - RED
- Penetrating Eye injuries – formulary status: Amber 2- initial prescription to be prescribed by Hospital Dr then subsequent continuation treatment to be prescribed on FP10 and to obtain from GP
|
|
|
Ofloxacin (Exocin®)
|
Formulary
|
Ophthalmic solution 0.3% (5ml)
|
|
|
| 11.03.02 |
Antifungals |
|
|
| 11.03.03 |
Antivirals |
|
|
Ganciclovir 0.15% eye gel (Virgan®)
|
Formulary
|
|
|
|
| 11.03.04 |
Antiamoebics |
|
|
| 11.04 |
Corticosteroids and other anti-inflammatory preparations |
|
|
| 11.04.01 |
Corticosteroids |
|
|
Betamethasone (Betnesol)
|
Formulary
|
Eye drops 0.1%
Eye ointment 0.1%
|
|
|
Betamethasone 0.1% with Neomycin 0.5%
|
Formulary
|
Eye drops (10ml)
|
|
|
Dexamethasone (Maxidex®)
|
Formulary
|
Eye drops 0.1% + hypromellose 0.5%
|
|
|
Dexamethasone (Minims® Dexamethasone)
|
Formulary
|
Eye drops 0.1%
|
|
|
Dexamethasone 0.1% with Neomycin 0.35% and Polymyxin B sulphate (Maxitrol®)
|
Formulary
|
Eye drops (5ml)
Eye ointment (3.5g)
|
|
|
Dexamethasone 700 microgram intravitreal implant (Ozurdex®)
|
Restricted
|
|
 NICE TA229: Macular oedema (retinal vein occlusion) - dexamethasone
NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema
|
Fluocinolone intravitreal implant (Iluvien ®)
|
Restricted
|
|
NICE TA301: Diabetic macular oedema - fluocinolone acetonide intravitreal implant (rapid review of TA271)
NICE TA590: Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis
|
Fluorometholone (FML®)
|
Formulary
|
Ophthalmic suspension 0.1%
|
|
|
Prednisolone (Minims® Prednisolone Sodium Phosphate)
|
Formulary
|
Eye drops 0.5%
|
|
|
Prednisolone (Pred Forte®)
|
Formulary
|
Eye drops 1%
|
|
|
Prednisolone (Predsol®)
|
Formulary
|
Eye drops 0.5%
|
|
|
Tobramycin 0.3% with dexamethasone 0.1% eye drops (Tobradex®)
|
Formulary
|
|
|
|
| 11.04.01 |
Intravitreal corticosteroids |
|
|
| 11.04.02 |
Other anti-inflammatory preparations |
|
|
Antazoline Sulphate 0.5% with Xylometazoline HCl 0.05% (Otrivine-Antistin®)
|
Formulary
|
Otrivine-Antistin eye drops are on the PCT's formulary.
Eye drops (10ml)
|
|
|
Azelastine Hydrochloride (Optilast®)
|
Formulary
|
Azelastine eye drops are on the PCT's formulary.
Eye drops 0.05%
|
|
|
Sodium Cromoglicate
|
Formulary
|
Eye drops 2%
|
|
|
| 11.05 |
Mydriatics and cycloplegics |
|
|
Ophthalmic Insert: Phenylephrine hydrochloride 5.4mg and Tropicamide 280mcg (Mydriasert®)
|
Formulary
|
|
|
|
Tropicamide with phenylephrine and lidocaine injection (Mydrane®)
|
Restricted
|
1 ml of solution for injection contains 0.2 mg of tropicamide, 3.1 mg of phenylephrine hydrochloride and 10 mg of lidocaine hydrochloride.
For use by ophthalmology only
|
|
|
| 11.05 |
Antimuscarinics |
|
|
Atropine Sulphate
|
Formulary
|
Eye drops 1%
|
|
|
Atropine Sulphate single use (Minims® Atropine Sulphate)
|
Formulary
|
Eye drops 1%
|
|
|
Cyclopentolate Hydrochloride
|
Formulary
|
Eye drops 0.5% and 1%
|
|
|
Cyclopentolate Hydrochloride single use (Minims® Cyclopentolate Hydrochloride)
|
Formulary
|
Eye drops 0.5% and 1%
|
|
|
Homatropine Hydrobromide
|
Formulary
|
Eye drops 1% and 2%
|
|
|
Tropicamide (Mydriacyl®)
|
Formulary
|
Eye drops 1%
|
|
|
Tropicamide single use (Minims® Tropicamide)
|
Formulary
|
Eye drops 0.5% and 1%
|
|
|
| 11.05 |
Sympathomimetics |
|
|
Phenylephrine Hydrochloride
|
Formulary
|
Eye drops 2.5%
|
|
|
Phenylephrine Hydrochloride (Minims® Phenylephrine Hydrochloride )
|
Formulary
|
Eye drops 2.5% and 10%
|
|
|
| 11.06 |
Treatment of glaucoma |
|
|
|
|
| 11.06 |
Beta-blockers |
|
|
Timolol Maleate drops
|
First Choice
|
Eye drops 0.25% and 0.5%
|
|
|
Levobunolol Hydrochloride
|
Second Choice
|
Eye drops 0.5%
|
|
|
Timolol 0.1% UDV eye gel (Tiopex®)
|
Formulary
|
First line preservative free beta blocker
|
|
|
Levobunolol Hydrochloride 0.5% unit dose vials
|
Formulary
|
Preservative free
|
|
|
| 11.06 |
Prostaglandin analogues |
|
|
Latanoprost 0.005% eye drops
|
First Choice
|
First line prostaglandin analogue
|
|
|
Bimatoprost (Lumigan®)
|
Second Choice
|
Eye drops 100micrograms/ml
(NOTE 300microgram/ml drops discontinued June 2015)
|
|
|
Travoprost (Travatan®)
|
Third Choice
|
Eye drops 40micrograms/ml
|
|
|
Bimatoprost with Timolol (Ganfort®)
|
Formulary
|
Bimatoprost 300micrograms/ml & timolol 5mg/ml drops
|
|
|
Latanoprost 0.005% single use eye drops (Monoprost ®)
|
Formulary
|
First line preservative free prostaglandin analogue
|
|
|
Bimatoprost single use eye drops 0.03% (Lumigan)
(®)
|
Formulary
|
2nd line preservative free prostaglandin analogue
|
|
|
Latanoprost 0.005% with Timolol 0.5% eye drops
|
Formulary
|
|
|
|
Travoprost with Timolol (DuoTrav®)
|
Formulary
|
Eye drops travoprost 40micrograms/ml & timolol 5mg/ml
|
|
|
| 11.06 |
Sympathomimetics |
|
|
Brimonidine Tartrate (Alphagan®)
|
First Choice
|
Eye drops 0.2%
|
|
|
Brimonidine Tartrate 0.2% with Timolol 0.5% (Combigan®)
|
Formulary
|
|
|
|
| 11.06 |
Carbonic anhydrase inhibitors and systemic drugs |
|
|
Brinzolamide (Azopt®)
|
First Choice
|
Eye drops 10mg/ml
|
|
|
Brinzolamide 1% with Timolol 0.5% (Azarga®)
|
Formulary
|
|
|
|
Brinzolomide 1% with brimonidine 0.2% eye drops (Simbrinza®)
|
Restricted
|
Initiation by ophthalmologists only in patients resistant to standard tratments
|
|
|
Dorzolomide (Trusopt®)
|
Restricted
|
For continuation only
Eye drops 2%
|
|
|
Dorzolomide 2% with Timolol 0.5% (Cosopt®)
|
Formulary
|
Eye drops (5ml)
|
|
|
Dorzolomide 2% with Timolol 0.5% unit dose eye drops (Cosopt®)
|
Formulary
|
1st line preservative free carbonic anhydrase inhibitor
|
|
|
Acetazolamide (Diamox®)
|
Formulary
|
Tablets 250mg
Injection 500mg
|
|
|
Acetazolamide (Diamox® SR)
|
Formulary
|
Capsules 250mg M/R
|
|
|
| 11.06 |
Miotics |
|
|
Pilocarpine
|
Formulary
|
Eye drops 1%, 2%, and 4%
Eye drops MINIMS 2% (20 x 0.5ml)
|
|
|
| 11.07 |
Local anaesthetics |
|
|
Lidocaine hydrochloride 4% and fluorescein sodium 0.25% drops (Minims® Lidocaine and Fluorescein)
|
Formulary
|
|
|
|
Oxybuprocaine Hydrochloride (Minims® )
|
Formulary
|
Eye drops 0.4%
|
|
|
Proxymetacaine Hydrochloride (Minims®)
|
Formulary
|
Eye drops 0.5%
|
|
|
Tetracaine Hydrochloride (Minims® Amethocaine Hydrochloride)
|
Formulary
|
Eye drops 0.5% and 1%
|
|
|
| 11.08 |
Miscellaneous ophthalmic preparations |
|
|
| 11.08.01 |
Tear deficiency, ocular lubricants, and astringents |
|
|
Hypromellose eye drops 0.3%
|
First Choice
|
Hypromellose is on the CCG's formulary as one of the first line ocular lubricants.
|
|
|
Carbomer 980 0.2% eye gel (Viscotears®)
|
First Choice
|
CURRENTLY UNAVAILABLE DUE TO MANUFACTURING PROBLEM - for alternative see Clinitas Gel
Liquid gel 0.2%
Viscotears is on the CCG's formulary as one of the first line ocular lubricants.
|
|
|
Hypromellose 1% (Isopto Alkaline®)
|
First Choice
|
Eye drops 1% (10ml)
Hypromellose is on the CCG's formulary as one of the first line ocular lubricants.
|
|
|
Polyvinyl alcohol 1.4%, povidone 0.6% Single Dose Units (Liquifilm Tears®)
|
First Choice
|
PRESERVATIVE FREE
|
|
|
Hypromellose 0.3% (Lumecare® Preservative Free Tear Drops )
|
First Choice
|
PRESERVATIVE FREE
Not routinely stocked in pharmacy but will be ordered on demand for patients in whom the standard first-line preservative free preparation is not suitable.
|
|
|
Liquid Paraffin (Lacri-Lube®)
|
Second Choice
|
CURRENTLY UNAVAILABLE DUE TO MANUFACTURING PROBLEM - for alternative see Xailin Night
Eye ointment (3.5g)
Lacri-lube is on the CCG's formulary as one of the second line ocular lubricants.
|
|
|
Carmellose Sodium (Celluvisc®)
|
Second Choice
|
PRESERVATIVE FREE
Single use: 0.5% and 1% drops
|
|
|
Sodium hyaluronidate 0.1% eye drops (Hylo-Tear®)
|
Third Choice
|
PRESERVATIVE FREE
Not routinely stocked in pharmacy. Ordered on demand when requested by Ophthalmology.
|
|
|
Sodium hyaluronidate 0.15% eye drops (Artelac Rebalance®)
|
Third Choice
|
Not routinely stocked in pharmacy. Ordered on demand when requested by Ophthalmology.
|
|
|
Sodium hyaluronidate 0.2% eye drops (Hylo-Forte®)
|
Third Choice
|
PRESERVATIVE FREE
Not routinely stocked in pharmacy. Ordered on demand when requested by Ophthalmology.
|
|
|
Carbomer 980 0.2% eye gel (Clinitas gel®)
|
Formulary
|
Temporary replacement for Viscotears due to manufacturing problems.
|
|
|
Liquid Paraffin (Xailin Night Eye Ointment (5g)®)
|
Formulary
|
Temporary replacement for Lacri-Lube due to manufacturing problems.
Eye ointment, white soft paraffin 57.3%, liquid paraffin 42.5%, wool alcohols 0.2%
|
|
|
Sodium Chloride (Balanced Salt Solution)
|
Formulary
|
Solution (36 x 15ml)
|
|
|
Sodium Chloride (Minims® Saline)
|
Formulary
|
Eye drops 0.9% (20 x 0.5ml)
|
|
|
Ciclosporin 0.1% eye drops (Ikervis®)
|
Restricted
|
For initiation by ophthalmologists only
|
NICE TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
|
| 11.08.02 |
Ocular diagnostic and peri-operative preparations and photodynamic treatment |
|
|
Aflibercept (Eylea®)
|
Restricted
|
|
NICE TA294: Macular degeneration (wet age-related) - aflibercept (1st line)
NICE TA305: Macular oedema (central retinal vein occlusion) - aflibercept solution for injection
NICE TA307: Colorectal cancer (metastatic) - aflibercept
NICE TA346: Aflibercept for treating diabetic macular oedema
NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
NICE TA486: Aflibercept for treating choroidal neovascularisation
|
Ocriplasmin intravitreal injection (Jetrea®)
|
Restricted
|
|
NICE TA297: Vitreomacular traction - ocriplasmin
|
| 11.08.02 |
Ocular diagnostic preparations |
|
|
Fluorescein injection 10% (Anatera(r))
|
Formulary
|
|
|
|
Fluorescein Sodium (Minims®)
|
Formulary
|
Eye drops 1% and 2%
|
|
|
| 11.08.02 |
Ocular peri-operative drugs |
|
|
Acetylcholine Chloride (Miochol-E®)
|
Formulary
|
Intra-ocular irrigation 10mg/ml
|
|
|
Apraclonidine 0.5% eye drops (Iopidine®)
|
Formulary
|
5ml bottle
For short-term adjunctive treatment of chronic glaucoma in patients not adequately controlled by another drug
|
|
|
Apraclonidine 1% unit dose eye drops (Iopidine®)
|
Formulary
|
Ophthalmic solution 1%
For control or prevention of postoperative elevation of intra-ocular pressure after anterior segment laser surgery
|
|
|
Diclofenac Sodium (Voltarol® Ophtha)
|
Formulary
|
Eye drops 0.1%
|
|
|
Ketorolac Trometamol (Acular®)
|
Formulary
|
Eye drops 0.5%
|
|
|
| 11.08.02 |
Subfoveal choroidal neovascularisation |
|
|
Ranibizumab (Lucentis®)
|
Restricted
|
Intravitreal injection 2.3mg/0.23ml (10mg/ml)
|
NICE TA274: Macular oedema (diabetic)
NICE TA283: Macular oedema (retinal vein occlusion)
NICE TA298: Choroidal neovascularisation (pathological myopia)
|
| 11.08.02 |
Vitreomacular traction |
|
|
| 11.08.03 |
Reduction of elevated intra-ocular pressure |
|
|
| 11.09 |
Contact lenses |
|
|
| 11.99.99.99 |
Miscellaneous |
|
|
| 11.99.99.99 |
Antifungals |
|
|
| 11.99.99.99 |
Cytotoxics / wound healing modulators |
|
|
| 11.99.99.99 |
Fibrinolytic drugs |
|
|
| 11.99.99.99 |
Glues - ocular |
|
|
| 11.99.99.99 |
Immunosuppressants |
|
|
| 11.99.99.99 |
Treatment of burns |
|
|
| 11.99.99.99 |
Visco-elastics |
|
|
| 11.99.99.99 |
Other |
|
|
| .... |
| Non Formulary Items |
Acetylcysteine
|
Non Formulary
|
|
|
|
Acetylcysteine 5% with Hypromellose 0.35% (Ilube®)
|
Non Formulary
|
Eye drops (10ml) |
|
|
Aciclovir eye ointment 3% (Zovirax®)
|
Non Formulary
|
|
 Dec 18 - Aciclovir eye ointment discontinuation
|
Alteplase
|
Non Formulary
|
|
|
|
Amikacin
|
Non Formulary
|
|
|
|
Amo Complete
|
Non Formulary
|
|
|
|
Amphotericin
|
Non Formulary
|
|
|
|
Azithromycin Dihydrate 1.5% Single Use Eye Drops (Azyter®)
|
Non Formulary
|
|
|
|
Betaxolol Hydrochloride (Betoptic®)
|
Non Formulary
|
Removed Dec 15
Ophthalmic solution 0.5%
Ophthalmic suspension 0.25% |
|
|
Bethamethasone (Vista-Methasone®)
|
Non Formulary
|
|
|
|
Bethamethasone with Neomycin (Vista-Methasone-N®)
|
Non Formulary
|
|
|
|
Bevacizumab (Avastin®)
|
Non Formulary
|
|
|
|
Boston Advance Cleaner
|
Non Formulary
|
|
|
|
Boston Advance Conditioning Solution
|
Non Formulary
|
|
|
|
Bromofenac 0.09% eye drops (Yellox ®)
|
Non Formulary
|
|
|
|
Carbomers (GelTears®)
|
Non Formulary
|
|
|
|
Carbomers (Liposic®)
|
Non Formulary
|
|
|
|
Carbomers (liquivisc®)
|
Non Formulary
|
|
|
|
Carmellose Sodium 0.5% Single Use Eye Drops (Carmize® )
|
Non Formulary
|
|
|
|
Carteolol Hydrochloride (Teoptic®)
|
Non Formulary
|
Removed Dec 15
Eye drops 1% and 2% |
|
|
Ceftazidime
|
Non Formulary
|
|
|
|
Cefuroxime
|
Non Formulary
|
|
|
|
Chloramphenicol (Chloromycetin®)
|
Non Formulary
|
|
|
|
Cocaine
|
Non Formulary
|
|
|
|
Dexamethasone with Antibacterials (Sofradex®)
|
Non Formulary
|
|
|
|
Diclofenac Sodium (Voltarol® Ophtha multidose)
|
Non Formulary
|
|
|
|
Dipivefrine Hydrochloride (Propine®)
|
Non Formulary
|
|
|
|
Disodium Edetate 0.37%
|
Non Formulary
|
|
|
|
Econazole
|
Non Formulary
|
|
|
|
Emedastine (Emadine®)
|
Non Formulary
|
|
|
|
Epinastine Hydrochloride (Relestat®)
|
Non Formulary
|
|
|
|
Erythromycin
|
Non Formulary
|
|
|
|
Fluorouracil
|
Non Formulary
|
|
|
|
Flurbiprofen Sodium (Ocufen®)
|
Non Formulary
|
|
|
|
Foscarnet
|
Non Formulary
|
|
|
|
Ganciclovir
|
Non Formulary
|
|
|
|
Gentamicin (Genticin®)
|
Non Formulary
|
|
|
|
Gentamicin single use (Minims® Gentamicin Sulphate)
|
Non Formulary
|
|
|
|
Glycerin
|
Non Formulary
|
|
|
|
Hydrocortisone Acetate
|
Non Formulary
|
|
|
|
Hydrocortisone Acetate with Neomycin (Neo-Cortef®)
|
Non Formulary
|
|
|
|
Hydroxyethylcellulose (Minims® Artificial Tears)
|
Non Formulary
|
|
|
|
Hydroxypropyl Guar (Systane®)
|
Non Formulary
|
|
|
|
Hydroxypropyl Guar and Sorbitol Eye Drops (Systane® Ultra )
|
Non Formulary
|
|
|
|
Hylauronidase (Hyalase®)
|
Non Formulary
|
|
|
|
Hypromellose (Isopto Plain®)
|
Non Formulary
|
|
|
|
Hypromellose 0.3% with Dextran 70 0.1% (Tears naturale®)
|
Non Formulary
|
|
|
|
Hypromellose single use (Artelac® SDU)
|
Non Formulary
|
|
|
|
Indocyanine green
|
Non Formulary
|
|
|
|
Ketotifen (Zaditen®)
|
Non Formulary
|
|
|
|
Latanoprost (Xalatan®)
|
Non Formulary
|
See generic product |
|
|
Latanoprost 0.005% with Timolol 0.5% (Xalacom®)
|
Non Formulary
|
See generic equivalent |
|
|
Levobunolol Hydrochloride (Betagan®)
|
Non Formulary
|
|
|
|
levofloxacin (Oftaquix®)
|
Non Formulary
|
|
|
|
Liquid Paraffin (Lubi-Tears®)
|
Non Formulary
|
|
|
|
Liquid Paraffin Eye Ointment (VitA-POS®)
|
Non Formulary
|
|
|
|
Lodoxamide (Alomide®)
|
Non Formulary
|
|
|
|
Loteprednol (Lotemax®)
|
Non Formulary
|
|
|
|
Mitomycin C
|
Non Formulary
|
|
|
|
Neodocromil Sodium (Rapitil®)
|
Non Formulary
|
Eye drops 2%
|
|
|
Neomycin Sulphate
|
Non Formulary
|
|
|
|
Nepafenac (Nevanac®)
|
Non Formulary
|
|
|
|
Olopatadine (Opatanol®)
|
Non Formulary
|
|
|
|
Oxysept 1 Step
|
Non Formulary
|
|
|
|
Paraffin Yellow Soft (Simple Eye Ointment)
|
Non Formulary
|
Ointment (4g) |
|
|
Pegaptanib Sodium (Macugen®)
|
Non Formulary
|
|
|
|
Pilocaprine long acting (Pilogel®)
|
Non Formulary
|
|
|
|
Pilocarpine
|
Non Formulary
|
|
|
|
Polyhexanide
|
Non Formulary
|
|
|
|
Polymyxin B Sulphate (Polyfax®)
|
Non Formulary
|
Eye ointment discontinued |
|
|
Polyvinyl Alchohol (SnoTears®)
|
Non Formulary
|
|
|
|
Polyvinyl Alcohol (Liquifilm Tears®)
|
Non Formulary
|
|
|
|
Potassium Ascorbate
|
Non Formulary
|
|
|
|
Propamidine Isetionate (Brolene®)
|
Non Formulary
|
|
|
|
Providone (Oculotect®)
|
Non Formulary
|
|
|
|
Proxymetacaine Hydrochloride 0.5% with Fluorescein Sodium 0.25% (Minims®)
(PRODUCT DISCONTINUED)
|
Non Formulary
|
No longer available - replaced with lidocaine/fluorescein drops |
|
|
Rimexolone (Vexol®)
|
Non Formulary
|
|
|
|
Rose Bengal (Minims® Rose Bengal)
|
Non Formulary
|
|
|
|
Saline Solution
|
Non Formulary
|
|
|
|
Sodium Chloride
|
Non Formulary
|
|
|
|
Sodium Chloride 0.9% Solutions
|
Non Formulary
|
|
|
|
Sodium Citrate
|
Non Formulary
|
|
|
|
Sodium Cromoglicate (Catacrom®)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate
|
Non Formulary
|
|
|
|
Sodium Hyaluronate (Hylo-Forte®)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate (Hylo-Tear®)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate 0.15% Eye Drops (Lubristil®)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate 0.3% Single Use Eye Drops (Vismed® Gel )
|
Non Formulary
|
|
|
|
Sodium Hyaluronate with Lidocaine
|
Non Formulary
|
|
|
|
Tafluprost (Preservative Free) 15micrograms/ml (Saflutan®)
|
Non Formulary
|
|
|
|
Tear flow test strips (Sno Strips)
|
Non Formulary
|
|
|
|
Timolol 0.1% Single Use LA Eye Drops (Tiopex®)
|
Non Formulary
|
|
|
|
Timolol Maleate (timoptol®)
|
Non Formulary
|
|
|
|
Timolol Maleate Once-daily (Timoptol®-LA)
|
Non Formulary
|
|
|
|
Tissue Adhesive (Histacryl®)
|
Non Formulary
|
|
|
|
Total Care Daily Cleaner
|
Non Formulary
|
|
|
|
Total Care Disinfecting and Wetting Solution
|
Non Formulary
|
|
|
|
Trifluorothymidine
|
Non Formulary
|
|
|
|
Vancomycin
|
Non Formulary
|
|
|
|
Verteporfin (Visudyne®)
|
Non Formulary
|
|
|
|
Zinc Sulphate
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
"Amber 1" - These are medicines that require significant monitoring and the decision to treat with an AMBER medicine should be made by specialists only |
|
"Amber 2" - These are medicines that require little or no monitoring by the GP, but should only be prescribed in general practice after they have been recommended following specialist referral. |
|
"Red" - Secondary care only |
|
"Double Red" - NOT recommended for prescribing in either primary or secondary care |
|
Traffic light status to be confirmed |
|
May be prescribed in primary and secondary care |
|
|
|
